TREM1 and renal cell carcinoma: Accordingly, we found that TREM-1 levels decrease on activated PMN (unpublished findings), and Rodriguez et al. showed that CD16 is decreased on MDSC from RCC patients, which closely resembled activated healthy PMN (37).